What is the recommended treatment regimen for recurrent gonorrhea and other sexually transmitted infections?

Treatment for Recurrent Gonorrhea and Other STDs

For recurrent gonorrhea episodes, treat with ceftriaxone 500mg IM as monotherapy (or weight-based dosing), and critically, retest all patients 3-6 months after treatment since most recurrent episodes represent reinfection rather than treatment failure. 1, 2, 3

Understanding Recurrent Episodes: Reinfection vs. Treatment Failure

The key clinical distinction is that most recurrent STD episodes are reinfections, not treatment failures. This fundamentally changes management:

• High reinfection rates: Patients with documented chlamydia or gonorrhea have exceptionally high rates of reinfection within 6 months after treatment 1
• Partner treatment is critical: Most reinfections occur because sexual partners were not adequately treated
• True treatment failure is rare with recommended regimens, especially for gonorrhea in the United States where ceftriaxone MICs remain stable (<0.1% showing elevated resistance) 3

Treatment Regimens for Recurrent Episodes

Gonorrhea Treatment

Current first-line therapy:

• Ceftriaxone 500mg IM once (for patients <150 kg) 2, 3
• Ceftriaxone 1g IM once (for patients ≥150 kg)

Critical change from older guidelines: Azithromycin is NO LONGER part of routine dual therapy due to rapid rise in resistance (nearly 5% of isolates with elevated MICs by 2018) 3. Only add doxycycline if chlamydia coinfection has not been excluded.

Chlamydia Treatment

Preferred regimen:

• Doxycycline 100mg PO twice daily for 7 days 4, 2
• This is now preferred over azithromycin due to better efficacy for rectal infections (which often coexist with genital infections) 4

Alternative:

• Azithromycin 1g PO single dose (only for populations with adherence concerns or confidentiality issues) 1

Management Algorithm for Recurrent Episodes

Step 1: Determine if True Recurrence

• Timing matters: If symptoms recur <3-4 weeks after treatment, consider:

  • Treatment non-compliance
  • Untreated partner exposure
  • Possible resistance (rare)

• Test-of-cure is NOT routinely needed for uncomplicated urogenital/rectal gonorrhea or chlamydia treated with recommended regimens 1, 5

Step 2: Retest and Retreat

• Mandatory retesting at 3-6 months after any gonorrhea or chlamydia diagnosis, regardless of whether partners were reportedly treated 1
• For pregnant women with antenatal gonococcal infection: retest in third trimester unless recently treated 5
• Treat any new positive test with standard first-line regimens

Step 3: Address Partner Treatment

• Instruct patients to abstain from sex for 7 days after single-dose therapy or until completion of 7-day regimen AND until all partners are treated 1
• Partner referral and expedited partner therapy are essential to break reinfection cycles

Step 4: Consider Resistance Only If:

• Documented treatment failure with recommended regimen
• Recent travel to/from Asia, Pacific, Hawaii, or California (quinolone resistance concerns for older regimens) 6
• Pharyngeal gonorrhea (requires test-of-cure due to higher treatment failure rates) 2

Special Considerations

When to Suspect Treatment Failure vs. Reinfection

Do NOT retreat based on symptoms alone without documented signs or laboratory evidence of urethral inflammation 1. Consider:

• Chronic prostatitis/chronic pelvic pain syndrome in males with persistent symptoms >3 months
• Alternative diagnoses (Mycoplasma genitalium responds better to azithromycin than doxycycline) 1

Resistance Surveillance

• If treatment failure is suspected, culture and susceptibility testing is mandatory 6
• Ceftriaxone resistance remains extremely rare in the US but is increasing internationally 3, 7
• Few alternative therapies exist for cephalosporin-allergic patients; no recommended alternatives for pharyngeal gonorrhea 3

Pregnancy

• Pregnant women should receive the same dual therapy (ceftriaxone + azithromycin if needed) 5
• Doxycycline is contraindicated in pregnancy; use azithromycin for chlamydia

Common Pitfalls to Avoid

1. Don't assume resistance: The vast majority of recurrent episodes are reinfections, not resistant organisms
2. Don't skip partner treatment: This is the most common cause of reinfection
3. Don't use azithromycin monotherapy for gonorrhea: Resistance has risen dramatically 3
4. Don't forget comprehensive STI screening: Test for syphilis and HIV in all patients with new STD diagnosis 1
5. Don't rely on symptoms alone for retreatment: Require objective evidence of infection 1

Screening to Prevent Recurrence

Implement routine screening in high-risk populations:

• All sexually active persons <30 years: annual screening 8
• Multiple partners or new partner: every 3-6 months 8
• High-prevalence populations: "opt-out" screening as frequently as every 3 months 8

This proactive approach reduces the reservoir of asymptomatic infections that drive reinfection cycles.